GSI 225 (Descovy 200 mg / 25 mg)
Generic Name: emtricitabine/tenofovir alafenamide
This pill with imprint "GSI 225" is Blue, Rectangle and has been identified as Descovy 200 mg / 25 mg. It is manufactured by Gilead Sciences, Inc..
Descovy is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. Descovy 200 mg / 25 mg is classified as a Schedule U controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- emtricitabine/tenofovir alafenamide
- Imprint:
- GSI 225
- Strength:
- 200 mg / 25 mg
- Color:
- Blue
- Shape:
- Rectangle
- Availability:
- Prescription only
- Drug Class:
- Antiviral combinations
- CSA Schedule:
- U - Unknown
- Manufacturer:
- Gilead Sciences, Inc.
More about Descovy (emtricitabine / tenofovir alafenamide)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- 1 Review – Add your own review/rating
- Drug class: antiviral combinations
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
